IndraLab

Statements

Hydroxychloroquine inhibits SARS-CoV-2. 7 / 7
| 7
eidos
"427 Hydroxychloroquine , a potential antiviral compound has been suggested to inhibit 428 SARS-CoV-2 by blocking fusion to the cell membrane , ( Fox , 1993 ; Yao et al ., 2020 ) ."
| DOI
eidos
"Hydroxychloroquine inhibits SARS-CoV-2 in vitro at concentrations achievable in human lung tissue ."
32293710
eidos
"Chloroquine and hydroxychloroquine inhibit in vitro SARS-CoV-2 [ 151 ] ."
32423059
eidos
"HCQ and AZM can suppress SARS-CoV-2 proliferation in vitro and may slow the cell-to-cell spread of the virus ; a large case series evaluating this combination in early-stage patients reported an impressively low mortality rate ."
32650197
eidos
"There are in vitro studies that show both chloroquine and hydroxychloroquine inhibit SARS-CoV-2 in vitro , although hydroxychloroquine appears to be more potent [ 45 ] ."
32304191
eidos
"In vitro experiments demonstrated CQ and HCQ can reduce the activity of SARS-CoV-2 11 ."
32365207
eidos
"24 Chloroquine ( CQ ) and hydroxychloroquine ( HCQ ) have been shown to inhibit SARS-CoV-2 in vitro , and 25 HCQ seems more effective than chloroquine ."
32360856